Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection
2022 · Molecular Cancer · 81 citations
https://doi.org/10.1186/s12943-022-01594-w
R
Rui Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
1.5K
Citations
15
h-index
16
i10-index
Rui Liu is an academic researcher from Singleron Biotechnologies (china). The author has contributed to research in topics: Cancer Genomics and Diagnostics & Epigenetics and DNA Methylation & Pancreatic and Hepatic Oncology Research. The author has an h-index of 15, co-authored 34 publications.
ORCID: 0000-0002-1642-1243Papers by this author
worksHomologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer
2022 · BMC Cancer · 53 citations
https://doi.org/10.1186/s12885-022-09602-4
Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
2022 · BMC Medicine · 43 citations
https://doi.org/10.1186/s12916-022-02647-z
Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation
2023 · Respiratory Research · 26 citations
https://doi.org/10.1186/s12931-023-02449-8
Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000
2023 · Clinical Epigenetics · 26 citations
https://doi.org/10.1186/s13148-023-01543-4
GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing
2025 · Molecular Cancer · 7 citations
https://doi.org/10.1186/s12943-025-02367-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat